423 related articles for article (PubMed ID: 33752265)
41. Autoimmunity as a target for chimeric immune receptor therapy: A new vision to therapeutic potential.
Haddadi MH; Hajizadeh-Saffar E; Khosravi-Maharlooei M; Basiri M; Negahdari B; Baharvand H
Blood Rev; 2020 May; 41():100645. PubMed ID: 31813654
[TBL] [Abstract][Full Text] [Related]
42. Recognition of tumor glycans by antigen-presenting cells.
Aarnoudse CA; Garcia Vallejo JJ; Saeland E; van Kooyk Y
Curr Opin Immunol; 2006 Feb; 18(1):105-11. PubMed ID: 16303292
[TBL] [Abstract][Full Text] [Related]
43. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.
Unger WW; van Beelen AJ; Bruijns SC; Joshi M; Fehres CM; van Bloois L; Verstege MI; Ambrosini M; Kalay H; Nazmi K; Bolscher JG; Hooijberg E; de Gruijl TD; Storm G; van Kooyk Y
J Control Release; 2012 May; 160(1):88-95. PubMed ID: 22366522
[TBL] [Abstract][Full Text] [Related]
44. Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies.
Greco B; Malacarne V; De Girardi F; Scotti GM; Manfredi F; Angelino E; Sirini C; Camisa B; Falcone L; Moresco MA; Paolella K; Di Bono M; Norata R; Sanvito F; Arcangeli S; Doglioni C; Ciceri F; Bonini C; Graziani A; Bondanza A; Casucci M
Sci Transl Med; 2022 Jan; 14(628):eabg3072. PubMed ID: 35044789
[TBL] [Abstract][Full Text] [Related]
45. Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis.
Colomb F; Giron LB; Trbojevic-Akmacic I; Lauc G; Abdel-Mohsen M
Curr HIV/AIDS Rep; 2019 Apr; 16(2):151-168. PubMed ID: 30707400
[TBL] [Abstract][Full Text] [Related]
46. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
Madsen CB; Lavrsen K; Steentoft C; Vester-Christensen MB; Clausen H; Wandall HH; Pedersen AE
PLoS One; 2013; 8(9):e72413. PubMed ID: 24039759
[TBL] [Abstract][Full Text] [Related]
47. Chemically engineered glycan-modified cancer vaccines to mobilize skin dendritic cells.
Duinkerken S; Li RE; van Haften FJ; de Gruijl TD; Chiodo F; Schetters STT; van Kooyk Y
Curr Opin Chem Biol; 2019 Dec; 53():167-172. PubMed ID: 31678713
[TBL] [Abstract][Full Text] [Related]
48. Chimeric antigen receptor T-cell therapy for cancer: a basic research-oriented perspective.
Han C; Kwon BS
Immunotherapy; 2018 Mar; 10(3):221-234. PubMed ID: 29370727
[TBL] [Abstract][Full Text] [Related]
49. CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD.
Imura Y; Ando M; Kondo T; Ito M; Yoshimura A
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32525846
[TBL] [Abstract][Full Text] [Related]
50. Structural and immunological characterization of the N-glycans from the major yellow jacket allergen Ves v 2: the N-glycan structures are needed for the human antibody recognition.
Seppälä U; Selby D; Monsalve R; King TP; Ebner C; Roepstorff P; Bohle B
Mol Immunol; 2009 Jun; 46(10):2014-21. PubMed ID: 19375166
[TBL] [Abstract][Full Text] [Related]
51. Therapeutic antibody glycosylation impacts antigen recognition and immunogenicity.
Wolf B; Piksa M; Beley I; Patoux A; Besson T; Cordier V; Voedisch B; Schindler P; Stöllner D; Perrot L; von Gunten S; Brees D; Kammüller M
Immunology; 2022 Jul; 166(3):380-407. PubMed ID: 35416297
[TBL] [Abstract][Full Text] [Related]
52. Evolution of chimeric antigen receptor (CAR) T cell therapy: current status and future perspectives.
Lee YH; Kim CH
Arch Pharm Res; 2019 Jul; 42(7):607-616. PubMed ID: 30830661
[TBL] [Abstract][Full Text] [Related]
53. Recent advances in tumor associated carbohydrate antigen based chimeric antigen receptor T cells and bispecific antibodies for anti-cancer immunotherapy.
Rashidijahanabad Z; Huang X
Semin Immunol; 2020 Feb; 47():101390. PubMed ID: 31982247
[TBL] [Abstract][Full Text] [Related]
54. The role of glycosylation in clinical allergy and immunology.
Hale RC; Morais D; Chou J; Stowell SR
J Allergy Clin Immunol; 2024 Jan; 153(1):55-66. PubMed ID: 37717626
[TBL] [Abstract][Full Text] [Related]
55. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays.
Chen S; LaRoche T; Hamelinck D; Bergsma D; Brenner D; Simeone D; Brand RE; Haab BB
Nat Methods; 2007 May; 4(5):437-44. PubMed ID: 17417647
[TBL] [Abstract][Full Text] [Related]
56. Bacterial and viral superantigens: roles in autoimmunity?
Acha-Orbea H
Ann Rheum Dis; 1993 Mar; 52 Suppl 1(Suppl 1):S6-16. PubMed ID: 8481060
[TBL] [Abstract][Full Text] [Related]
57. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.
Marciani DJ
Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131
[TBL] [Abstract][Full Text] [Related]
58. Trichuris suis-induced modulation of human dendritic cell function is glycan-mediated.
Klaver EJ; Kuijk LM; Laan LC; Kringel H; van Vliet SJ; Bouma G; Cummings RD; Kraal G; van Die I
Int J Parasitol; 2013 Mar; 43(3-4):191-200. PubMed ID: 23220043
[TBL] [Abstract][Full Text] [Related]
59. Glycans modulate immune responses in helminth infections and allergy.
van Die I; Cummings RD
Chem Immunol Allergy; 2006; 90():91-112. PubMed ID: 16210905
[TBL] [Abstract][Full Text] [Related]
60. Improving the ability of CAR-T cells to hit solid tumors: Challenges and strategies.
Zhang ZZ; Wang T; Wang XF; Zhang YQ; Song SX; Ma CQ
Pharmacol Res; 2022 Jan; 175():106036. PubMed ID: 34920118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
